Covid-19: BioNTech CEO says will work with others to boost vaccine capacity

By: |
December 26, 2020 10:36 PM

BioNTech Chief Executive Ugur Sahin said his company would be open to cooperating with others as it looks to increase production capacity for its COVID-19 vaccine developed with Pfizer and was considering opening an office in Turkey.

Pfizer-BioNTech Covid vaccine"We want to produce more than 1 billion doses with Pfizer next year. We need to distribute them to over 80 countries," said BioNTech Chief Executive Ugur Sahin as reported by Turkey's state-run Anadolu news agency.

BioNTech Chief Executive Ugur Sahin said his company would be open to cooperating with others as it looks to increase production capacity for its COVID-19 vaccine developed with Pfizer and was considering opening an office in Turkey.

Sahin repeated BioNTech aimed to distribute 1.3 billion doses of its vaccine by the end of 2021 and that 70% of the world needed to be vaccinated by next winter to go back to “normal life”, according to an interview with Turkey’s state-run Anadolu news agency.

“We want to produce more than 1 billion doses with Pfizer next year. We need to distribute them to over 80 countries,” he was cited as saying. “This is not easy. Vaccines are made in a complex manner. We will start cooperating with other companies again,” he added.

“If we can carry out our plans on how to increase capacity, we can disclose it in January or February. I believe we can increase it. We don’t have a guaranteed plan yet.”

Ankara has agreed to buy 4.5 million doses of the BioNTech and Pfizer vaccine, with an option to procure 30 million more doses later.

Sahin, the son of a Turkish immigrant to Germany, told Anadolu BioNTech was in talks with Turkey’s state scientific agency Tubitak, and would aim to deliver the 30 million doses to the country by the end of 2021.

“It is a great joy to be able to help people in Turkey,” Sahin was quoted as saying by Anadolu.

“We also want to carry out research in Turkey. We have talks with Tubitak, we have started working with some professors at universities.

We want to open a branch of the BioNTech company in Turkey,” he said, adding he hoped to start clinical work on cancer research in the country in the summer of 2021.

Turkey has also agreed to buy 50 million doses of China’s Sinovac vaccine, CoronaVac, and a first shipment of 3 million doses of CoronaVac arrives on Monday.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Maharashtra suspends corona vaccination drive till Monday due to Co-Win app glitches
2V-Day report: One ‘severe’, 51 ‘minor’ cases of adverse events reported among health workers in Delhi
3Bird flu in poultry confirmed in 9 districts of Maharashtra; culling operation on in MP, Chhattisgarh